Manufacturing and quality control data: all parameters have been inspected and approved during the manufacturing process.All parameters have been assessed as meeting specifications.Investigation: visual inspection: a deformation of the outer housing of the valve was observed through the visual inspection.The prosa valve housing was subsequently measured and confirmed the presence of a deformation.The housing deformation measured at -0.130mm, outside the tolerance of 0 +/- 0.02mm.Permeability test: a permeability test has indicated that the valve has a blockage.Adjustment test: the valve was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Results: we have dismantled the valve.Inside the valve we have found significant build-up of substances (likely protein).Based on our investigation, we are unable to substantiate the claim of non-adjustability.The valve is adjustable to all specified settings.However, through the investigation we have determined that the prosa valve is occluded, likely due to the deposits obsereved inside the valve.As described in our literature, the problem encountered is one of the known inevitable risks of hc-therapy by shunt implants.
|